BioCentury | Dec 19, 2019

Raising PDLIM2 expression to treat lung cancer

...cell and dendritic cell activation and infiltration into tumors, and prevented paclitaxel-induced chemotherapy resistance. TARGET/MARKER/PATHWAY: PDZ and LIM domain 2 (PDLIM2)...
...Pittsburgh, Pa. email: CONTACT: Zhaoxia Qu, same affiliation as above email: Claire Quang University of Pittsburgh PDZ and LIM domain 2 (PDLIM2)...
BioCentury | Oct 31, 2011

Lessons from PSA debate

While the medical community debates a U.S. task force's recommendation against PSA screening for prostate cancer, the implications are far broader: The task force's methodology for subjectively balancing benefit and harm is being applied to...
Items per page:
1 - 2 of 2